• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MYMD

MYMD

MyMD Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.81

-0.01 (-0.55%)

Company Profile

CEO

Ian Rhodes CPA

IPO Date

2014-01-23

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.79

Prev. Close

$1.82

Day Low

$1.78

Day High

$1.84

52W Low

$1.75

52W High

$63.90

Market Cap

$0.00B

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

4

Avg Positive

31.3%

Avg Negative

1.0%

Avg Neutral

67.8%

News Feed

MyMD Pharmaceuticals' Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis

Business Wire·7/27/2021·↑ positive

MyMD Pharmaceuticals Set to Join Russell Microcap® Index

Business Wire·6/7/2021·↑ positive

Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals' Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit

Business Wire·4/28/2021·↑ positive

MyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent and Trademark Office for Synthetic Cannabinoid Compounds

Business Wire·4/22/2021·↑ positive